Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASM-024 in Healthy Subjects and Stable Moderate Asthma
NCT01793298Phase 2Terminated
- Sponsor
- Asmacure Ltée
- Start
- Mar 2013
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of asm-024 in asthma (5 arms), sponsored by Asmacure Ltée. Primary endpoints: Adverse Events at 7 days, Spirometry at 7 days and 1 more. Started Mar 2013; status: terminated.
02
Drugs
asm-024
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01793298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01793298.